A Novel Temozolomide–Perillyl Alcohol Conjugate Exhibits Superior Activity against Breast Cancer Cells <i>In Vitro</i> and Intracranial Triple-Negative Tumor Growth <i>In Vivo</i>
Molecular cancer therapeutics